Shareholders are encouraged to cast their votes in advance of the General Meeting or grant the Chair of the Board a proxy, with or without voting instructions.

The deadline for registration of attendance, advance votes, proxy or instructions is 22 May 2025 at 16:00 (CET). For attendance at the live event, please follow the instructions in the notice.

For further information, see the attached Notice of the Annual General Meeting, which can also be accessed from the company's website (https://arctic-bioscience.com/investors/general-meetings/).

Board of Directors proposal:

Proposed board members for the next period are:

• Harald Nordal (chairperson) (reelection)
• Jan Endre Vartdal (reelection)
• Tore A. F. Tønseth (reelection)
• Marita Holstad (reelection)
• Olav Sindre Kriken (new)

Proposed new board member Olav Sindre Kriken is a Norwegian citizen from Ørsta based in Palo Alto, California. Mr. Kriken is an experienced Founder and Businessman with a solid record within business innovation and growth. He is skilled in Product-Led Growth, Business Modelling, Marketing Management and Digital Strategy. The nomination of Mr. Kriken to the company board is aligned with the company growth within product sales through established and new distributions channels with strategic utilization of the opportunities with AI and SoMe. 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.